1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 116. Oldham M M, Miller J L, Hagemann T M, Harrison D, Chavez-Bueno S, Johnson P N. Vancomycin dosage in overweight and obese children. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011; 68 : 2062-8
117. Miller J L, Hagemann T M. Use of pure opioid antagonists for management of opioid-induced pruritus. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011; 68 : 1419-25
118. Johnson P N, Miller J L, Gormley A K. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011; 31 : 609-20
119. Johnson P N, Miller J L, Boucher E A, Lubsch L, Girotto J E, Pesaturo K A, Lee B. Pediatric Pharmacy Advocacy Group Position Statement: Medication dosing in overweight and obese children. 2010
120. Gish E C, Miller J L, Gildon B, Johnson P N. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. The Annals of pharmacotherapy. 2010; 44 : 343-51
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
3. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.